Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ARS Pharma Inc | Pratik Shah | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 04 Jun 2024 | 2,665,800 | 7,490,404 | - | - | Common Stock | |
| ARS Pharma Inc | Pratik Shah | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 04 Jun 2024 | 2,665,800 | 7,490,404 | - | - | Common Stock | |
| ARS Pharma Inc | Pratik Shah | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Jun 2024 | 1,332,900 | 6,157,504 | - | 0 | Common Stock | |
| ARS Pharma Inc | Pratik Shah | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Jun 2024 | 1,332,900 | 1,332,900 | - | 0 | Common Stock | |
| Olema Pharma Inc | Graham Walmsley | Director | Sale of securities on an exchange or to another person at price $ 14.85 per share. | 04 Jun 2024 | 700,000 | 700,761 | - | 14.9 | 10,395,000 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Jun 2024 | 609,221 | 7,937,529 (43%) | 3% | - | Common Stock | |
| Geron Corp | John A. Scarlett | Director, Chairman, President and CEO | 04 Jun 2024 | 600,000 | 600,000 (0%) | 0% | 2.5 | 1,524,000 | Common Stock | |
| Geron Corp | John A. Scarlett | Director, Chairman, President and CEO | 04 Jun 2024 | 600,000 | 0 | - | - | Stock Option (right to buy) | ||
| Geron Corp | John A. Scarlett | Director, Chairman, President and CEO | 04 Jun 2024 | 600,000 | 600,000 (0%) | 0% | 4 | 2,400,000 | Common Stock | |
| Olema Pharma Inc | Graham Walmsley | Director | Sale of securities on an exchange or to another person at price $ 14.85 per share. | 04 Jun 2024 | 475,000 | 708,114 | - | 14.9 | 7,053,750 | Common Stock |
| Microvision Inc | Anubhav Verma | CFO | 04 Jun 2024 | 450,000 | 450,000 | - | - | Restricted Stock Units | ||
| Orasure Tech Inc | Carrie Eglinton Manner | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.65 per share. | 04 Jun 2024 | 401,618 | 1,181,039 (1%) | 0% | 4.7 | 1,867,524 | Common Stock |
| Teads Holding Co. | David Kostman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 400,000 | 400,000 | - | - | Performance Stock Units | |
| Tvardi Therapeutics Inc | Martin A. Vogelbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 390,000 | 390,000 | - | - | Stock Option (Right to Buy) | |
| Microvision Inc | Drew G. Markham | GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 360,000 | 360,000 | - | - | Restricted Stock Units | |
| Tvardi Therapeutics Inc | Martin A. Vogelbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 301,295 | 411,007 (0%) | 0% | 0 | Common Stock | |
| Best Buy | Richard M. Schulze | Chairman Emeritus | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Jun 2024 | 287,250 | 15,602,853 (6%) | 0% | 0 | Common Stock | |
| Best Buy | Richard M. Schulze | Chairman Emeritus | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Jun 2024 | 287,250 | 296,100 (0%) | 0% | 0 | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Jun 2024 | 283,123 | 283,122 (1%) | 1% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Jun 2024 | 283,122 | 0 (0%) | 1% | - | Common Stock | |
| Toast Inc (Class A) | Stephen Fredette | Director, President | 04 Jun 2024 | 250,000 | 462,500 | - | - | Class B Common Stock | ||
| Toast Inc (Class A) | Stephen Fredette | Director, President | 04 Jun 2024 | 250,000 | 287,500 | - | 0 | Class A Common Stock | ||
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | 04 Jun 2024 | 250,000 | 250,000 | - | - | Class A Common Stock | ||
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 21.03 per share. | 04 Jun 2024 | 250,000 | 0 | - | 21.0 | 5,258,275 | Class A Common Stock |
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | 04 Jun 2024 | 250,000 | 49,444,720 | - | - | Class B Common Stock | ||
| AlTi Global Inc (Class A) | Kevin Moran | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 236,967 | 236,967 | - | - | Peformance Restricted Stock Unit | |
| Marchex Inc (Class B) | Edwin A. Miller | Chief Executive Officer | 04 Jun 2024 | 200,000 | 218,066 (0%) | 0% | 1.4 | 272,000 | Class B Common Stock | |
| Microvision Inc | Anubhav Verma | CFO | 04 Jun 2024 | 200,000 | 295,006 (0%) | 0% | 0 | Common Stock | ||
| Microvision Inc | Anubhav Verma | CFO | 04 Jun 2024 | 200,000 | 0 | - | - | Restricted Stock Units | ||
| Microvision Inc | Anubhav Verma | CFO | 04 Jun 2024 | 200,000 | 200,000 | - | - | Restricted Stock Units | ||
| Teads Holding Co. | David Kostman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 200,000 | 695,767 | - | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Jeffrey L. Ives | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 195,000 | 195,000 | - | - | Stock Option (Right to Buy) | |
| Tvardi Therapeutics Inc | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 195,000 | 195,000 | - | - | Stock Option (Right to Buy) | |
| Tvardi Therapeutics Inc | Lisa von Moltke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 195,000 | 195,000 | - | - | Stock Option (Right to Buy) | |
| Tvardi Therapeutics Inc | Susan Shiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 195,000 | 195,000 | - | - | Stock Option (Right to Buy) | |
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.43 per share. | 04 Jun 2024 | 188,888 | 188,888 | - | 2.4 | 458,998 | Class A Common Stock |
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 188,888 | 1,148,456 | - | - | Stock Option (right to buy) | |
| Microvision Inc | Drew G. Markham | GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 186,250 | 222,950 (0%) | 0% | 0 | Common Stock | |
| Microvision Inc | Drew G. Markham | GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 186,250 | 0 | - | - | Restricted Stock Units | |
| Microvision Inc | Drew G. Markham | GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 186,250 | 186,250 | - | - | Restricted Stock Units | |
| AlTi Global Inc (Class A) | Spiros Maliagros | Director, Pres., Strategic Alternatives | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 182,072 | 182,072 | - | - | Peformance Restricted Stock Unit | |
| Evolus Inc | David Moatazedi | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.28 per share. | 04 Jun 2024 | 175,940 | 709,289 (2%) | 0% | 7.3 | 1,280,843 | Common Stock |
| Evolus Inc | David Moatazedi | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 175,940 | 1,006,079 | - | - | Stock Option (Right to Buy) | |
| Evolus Inc | David Moatazedi | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 12.59 per share. | 04 Jun 2024 | 175,940 | 533,349 (1%) | 0% | 12.6 | 2,214,486 | Common Stock |
| Coherus Biosciences Inc | Rita A. Karachun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 168,000 | 168,000 | - | - | Stock Option (Right to Buy) | |
| Evolus Inc | David Moatazedi | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.46 per share. | 04 Jun 2024 | 155,278 | 688,627 (2%) | 0% | 5.5 | 847,818 | Common Stock |
| Evolus Inc | David Moatazedi | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 12.92 per share. | 04 Jun 2024 | 155,278 | 533,349 (1%) | 0% | 12.9 | 2,006,456 | Common Stock |
| Evolus Inc | David Moatazedi | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 155,278 | 155,281 | - | - | Stock Option (Right to Buy) | |
| Tvardi Therapeutics Inc | Jeffrey L. Ives | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 150,647 | 198,485 (0%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 150,647 | 150,647 (0%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Lisa von Moltke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 150,647 | 183,009 (0%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Susan Shiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 150,647 | 202,085 (0%) | 0% | 0 | Common Stock | |
| Evolus Inc | David Moatazedi | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 12.73 per share. | 04 Jun 2024 | 140,214 | 533,349 (1%) | 0% | 12.7 | 1,784,686 | Common Stock |
| Teads Holding Co. | Asaf Porat | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 140,000 | 510,300 | - | 0 | Common Stock | |
| Lucid Grp Inc | Lisa Marie Lambert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 134,476 | 134,476 | - | 0 | Class A Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.58 per share. | 04 Jun 2024 | 126,014 | 7,685,501 (42%) | 0% | 1.6 | 199,619 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.63 per share. | 04 Jun 2024 | 126,014 | 7,811,515 (43%) | 0% | 1.6 | 205,516 | Common Stock |
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 19.73 per share. | 04 Jun 2024 | 119,049 | 69,839 | - | 19.7 | 2,348,813 | Class A Common Stock |
| Coherus Biosciences Inc | Georgia L. Erbez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 114,000 | 114,000 | - | - | Stock Option (Right to Buy) | |
| InnovAge Holding Corp | Richard A. Feifer | CHIEF MEDICAL OFFICER | 04 Jun 2024 | 108,226 | 243,234 | - | 0 | Common Stock, $0.001 par value | ||
| InnovAge Holding Corp | Nicole Damato | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 97,403 | 275,012 | - | 0 | Common Stock, $0.001 par value | |
| Lucid Grp Inc | Andrew N. Liveris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 96,822 | 685,386 | - | 0 | Class A Common Stock | |
| Lucid Grp Inc | Janet S. Wong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 96,822 | 150,111 | - | 0 | Class A Common Stock | |
| Lucid Grp Inc | Nichelle Maynard-Elliott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 96,822 | 150,111 | - | 0 | Class A Common Stock | |
| Lucid Grp Inc | Turqi Alnowaiser | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 96,822 | 2,214,626 | - | 0 | Class A Common Stock | |
| Lucid Grp Inc | Sherif S. Marakby | Director | 04 Jun 2024 | 96,822 | 145,209 | - | 0 | Class A Common Stock | ||
| Lucid Grp Inc | Chabi Nouri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 96,822 | 142,865 | - | 0 | Class A Common Stock | |
| Lucid Grp Inc | Ori Winitzer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 96,822 | 145,209 | - | 0 | Class A Common Stock | |
| AlTi Global Inc (Class A) | Nancy A. Curtin | Director, Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 96,580 | 96,580 | - | - | Peformance Restricted Stock Unit | |
| AlTi Global Inc (Class A) | Colleen A Graham | Global General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 94,237 | 94,237 | - | - | Restricted Stock Units | |
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 19.73 per share. | 04 Jun 2024 | 90,992 | 1,219,430 | - | 19.7 | 1,795,236 | Class A Common Stock |
| AlTi Global Inc (Class A) | Robert Weeber | Pres, Intl. Wealth Mmgt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 87,962 | 87,962 | - | - | Peformance Restricted Stock Unit | |
| InnovAge Holding Corp | Christine Bent | CHIEF OPERATIONS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 86,581 | 212,142 | - | 0 | Common Stock, $0.001 par value | |
| Fidelity National Fin Inc | Anthony J. Park | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 50.82 per share. | 04 Jun 2024 | 85,000 | 99,049 (0%) | 0% | 50.8 | 4,320,091 | Common Stock |
| Procept BioRobotics Corp | Taylor C. Harris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.18 per share. | 04 Jun 2024 | 81,550 | 131,336 | - | 5.2 | 422,429 | Common Stock |
| Procept BioRobotics Corp | Taylor C. Harris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 81,550 | 13,923 | - | - | Stock Option (Right to Buy) | |
| Steris PLC | Daniel A. Carestio | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 81,544 | 81,544 | - | - | Employee Stock Option (right to buy) | |
| GoPro Inc (Class A) | Alexander J. Lurie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 80,992 | 80,992 (0%) | 0% | 0 | Class A Common Stock | |
| GoPro Inc (Class A) | Kenneth A. Goldman | Director | 04 Jun 2024 | 80,992 | 86,660 (0%) | 0% | 0 | Class A Common Stock | ||
| GoPro Inc (Class A) | Peter Gotcher | Director | 04 Jun 2024 | 80,992 | 209,840 (0%) | 0% | 0 | Class A Common Stock | ||
| GoPro Inc (Class A) | Susan M. Lyne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 80,992 | 211,561 (0%) | 0% | 0 | Class A Common Stock | |
| GoPro Inc (Class A) | Tyrone Ahmad-Taylor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 80,992 | 137,856 (0%) | 0% | 0 | Class A Common Stock | |
| GoPro Inc (Class A) | Shaz Kahng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 80,992 | 186,916 (0%) | 0% | 0 | Class A Common Stock | |
| AlTi Global Inc (Class A) | Colleen A Graham | Global General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 77,092 | 77,092 | - | - | Peformance Restricted Stock Unit | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.43 per share. | 04 Jun 2024 | 75,649 | 538,751 | - | 33.4 | 2,528,984 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.43 per share. | 04 Jun 2024 | 75,400 | 539,000 | - | 33.4 | 2,520,479 | Class A Common Stock |
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 20.13 per share. | 04 Jun 2024 | 69,839 | 0 | - | 20.1 | 1,406,027 | Class A Common Stock |
| Flex Ltd | Revathi Advaithi | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 32.53 per share. | 04 Jun 2024 | 61,042 | 1,842,362 (0%) | 0% | 32.5 | 1,985,879 | Ordinary Shares |
| Teads Holding Co. | Asaf Porat | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 60,000 | 60,000 | - | - | Performance Stock Units | |
| Palo Alto | Lee Klarich | EVP, Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 60,000 | 1,038,745 | - | - | Stock Option (right to buy) | |
| Palo Alto | Lee Klarich | EVP, Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.50 per share. | 04 Jun 2024 | 60,000 | 226,542 (0%) | 0% | 64.5 | 3,870,198 | Common Stock |
| Roblox Corp (Class A) | Michael Guthrie | Chief Financial Officer | 04 Jun 2024 | 59,100 | 1,552,390 | - | - | Stock Option (Right to Buy) | ||
| Roblox Corp (Class A) | Michael Guthrie | Chief Financial Officer | 04 Jun 2024 | 59,100 | 374,633 | - | 35.2 | 2,082,920 | Class A Common Stock | |
| Roblox Corp (Class A) | Michael Guthrie | Chief Financial Officer | 04 Jun 2024 | 59,100 | 433,733 | - | 0.5 | 31,323 | Class A Common Stock | |
| Quince Therapeutics Inc | Brendan Hannah | CHIEF BUSINESS OFFICER AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 56,061 | 47,439 | - | - | Employee Stock Option (right to buy) | |
| Quince Therapeutics Inc | Brendan Hannah | CHIEF BUSINESS OFFICER AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.55 per share. | 04 Jun 2024 | 56,061 | 257,616 (0%) | 0% | 0.6 | 30,834 | Common Stock |
| Teads Holding Co. | Jason Kiviat | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 56,000 | 215,441 | - | 0 | Common Stock | |
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 20.13 per share. | 04 Jun 2024 | 53,452 | 1,165,978 | - | 20.1 | 1,076,122 | Class A Common Stock |
| Agilysys Inc | Ramesh Srinivasan | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 92.74 per share. | 04 Jun 2024 | 50,000 | 788,367 (3%) | 0% | 92.7 | 4,637,000 | Common Stock |
| Sangamo Therapeutics Inc | H. Stewart Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | James R. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | Margaret A. Horn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | Robert F. Carey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | Kenneth J. Hillan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | Karen L. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | John H. Markels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | Courtney Beers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| BlackLine Inc | Mark Partin | CHIEF FINANCIAL OFFICER | 04 Jun 2024 | 50,000 | 279,341 (0%) | 0% | 14 | 700,000 | Common Stock | |
| BlackLine Inc | Mark Partin | CHIEF FINANCIAL OFFICER | 04 Jun 2024 | 50,000 | 42,676 | - | - | Stock Option (Right to Buy) | ||
| SUNation Energy Inc | Scott M. Honour | Director | Sale of securities on an exchange or to another person at price $ 0.21 per share. | 04 Jun 2024 | 50,000 | 1,075,418 | - | 0.2 | 10,295 | Common Stock |
| Target | Brian C. Cornell | Director, Executive Officer | Sale of securities on an exchange or to another person at price $ 151.36 per share. | 04 Jun 2024 | 45,000 | 348,843 (0%) | 0% | 151.4 | 6,811,250 | Common Stock |
| BlackLine Inc | Mark Partin | CHIEF FINANCIAL OFFICER | 04 Jun 2024 | 44,029 | 235,312 (0%) | 0% | 47.3 | 2,082,528 | Common Stock | |
| LoanDepot Inc (Class A) | Anthony Hsieh | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.81 per share. | 04 Jun 2024 | 43,281 | 2,813,324 (4%) | 0% | 1.8 | 78,339 | Class A Common Stock |
| AlTi Global Inc (Class A) | Kevin Moran | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 41,356 | 41,356 | - | - | Restricted Stock Units | |
| Mitek Systems Inc | Scott R. Carter | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 12.39 per share. | 04 Jun 2024 | 40,355 | 161,392 (0%) | 0% | 12.4 | 499,998 | Common Stock |
| Mitek Systems Inc | Scott R. Carter | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 40,355 | 40,355 | - | - | Performance Restricted Stock Units | |
| Aldeyra Therapeutics Inc | Gary M. Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 40,282 | 40,282 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Martin J. Joyce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 40,282 | 40,282 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Richard Douglas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 40,282 | 40,282 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Ben Bronstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 40,282 | 40,282 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Neal Walker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 40,282 | 40,282 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Nancy Miller-Rich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 40,282 | 40,282 | - | - | Stock Option (Right to Buy) | |
| Catalyst Pharma Inc | Richard J. Daly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.01 per share. | 04 Jun 2024 | 40,000 | 252,147 (0%) | 0% | 4.0 | 160,400 | Common stock, par value $0.001 per share |
| Catalyst Pharma Inc | Richard J. Daly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 40,000 | 1,731,012 | - | - | Options to purchase common stock | |
| Snap-on | Nicholas T. Pinchuk | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 144.69 per share. | 04 Jun 2024 | 32,500 | 774,882 (1%) | 0% | 144.7 | 4,702,425 | Common Stock |
| Snap-on | Nicholas T. Pinchuk | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 32,500 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Arteris Inc | Wayne C. Cantwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 32,145 | 258,198 | - | 0 | Common Stock | |
| Gannett Co Inc | John Jeffry Louis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 30,864 | 560,193 (0%) | 0% | 0 | Common Stock | |
| Gannett Co Inc | Kevin M. Sheehan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 30,864 | 287,530 (0%) | 0% | 0 | Common Stock | |
| Gannett Co Inc | Theodore P. Janulis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 30,864 | 232,530 (0%) | 0% | 0 | Common Stock | |
| Gannett Co Inc | Laurence Tarica | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 30,864 | 1,039,663 (0%) | 0% | 0 | Common Stock | |
| Gannett Co Inc | Barbara W. Wall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 30,864 | 392,123 (0%) | 0% | 0 | Common Stock | |
| Gannett Co Inc | Debra A. Sandler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 30,864 | 224,225 (0%) | 0% | 0 | Common Stock | |
| Gannett Co Inc | Amy E. Reinhard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 30,864 | 119,400 (0%) | 0% | 0 | Common Stock | |
| Gannett Co Inc | Maha Al-Emam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 30,864 | 30,864 (0%) | 0% | 0 | Common Stock | |
| Jamf Holding Corp | Dean J. Hager | Director | Sale of securities on an exchange or to another person at price $ 15.46 per share. | 04 Jun 2024 | 30,442 | 339,639 | - | 15.5 | 470,688 | Common Stock, $0.001 par value |
| AlTi Global Inc (Class A) | Spiros Maliagros | Director, Pres., Strategic Alternatives | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 30,339 | 30,339 | - | - | Restricted Stock Units | |
| Cloudflare Inc (Class A) | Carl Ledbetter | Director | Sale of securities on an exchange or to another person at price $ 68.65 per share. | 04 Jun 2024 | 30,270 | 1,110,395 (1%) | 0% | 68.6 | 2,077,911 | Class A Common Stock |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 100.23 per share. | 04 Jun 2024 | 29,906 | 1,720,788 (3%) | 0% | 100.2 | 2,997,493 | Class A Common Stock |
| Expion360 Inc | John Yozamp | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.57 per share. | 04 Jun 2024 | 29,727 | 1,692,182 | - | 1.6 | 46,671 | Common Stock |
| AlTi Global Inc (Class A) | Brooke Connell | Pres, US Wealth Mgmt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 29,558 | 29,558 | - | - | Peformance Restricted Stock Unit | |
| AlTi Global Inc (Class A) | Nancy A. Curtin | Director, Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 28,475 | 28,475 | - | - | Restricted Stock Units | |
| Avidity Biosciences Inc | Sarah Boyce | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. | 04 Jun 2024 | 28,000 | 140,117 | - | 1.2 | 34,720 | Common Stock |
| Avidity Biosciences Inc | Sarah Boyce | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 28,000 | 817,015 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Sarah Boyce | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 27.42 per share. | 04 Jun 2024 | 28,000 | 112,117 | - | 27.4 | 767,780 | Common Stock |
| CVRx Inc | Joseph P. Slattery | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 27,250 | 27,250 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 27,250 | 27,250 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Mudit K. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 27,250 | 27,250 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Kirk Nielsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 27,250 | 27,250 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Martha Shadan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 27,250 | 27,250 | - | - | Stock Option (right to buy) | |
| Alset Inc | Fai Heng Chan | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.10 per share. | 04 Jun 2024 | 26,964 | 5,384,072 | - | 1.1 | 29,633 | Common Stock |
| AlTi Global Inc (Class A) | Stephen Yarad | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 26,871 | 26,871 | - | - | Peformance Restricted Stock Unit | |
| AlTi Global Inc (Class A) | Robert Weeber | Pres, Intl. Wealth Mmgt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 26,864 | 26,864 | - | - | Restricted Stock Units | |
| Western Digital | Robert W. Soderbery | EVP & GM, Flash Business | Sale of securities on an exchange or to another person at price $ 73.48 per share. | 04 Jun 2024 | 26,853 | 144,623 (0%) | 0% | 73.5 | 1,973,215 | Common Stock |
| Accuray Inc | Sandeep Chalke | SVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.70 per share. | 04 Jun 2024 | 26,799 | 531,341 (0%) | 0% | 1.7 | 45,612 | Common Stock |
| AlTi Global Inc (Class A) | Brooke Connell | Pres, US Wealth Mgmt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 26,102 | 26,102 | - | - | Restricted Stock Units | |
| Funko Inc (Class A) | Charles D. Denson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 25,500 | 25,500 | - | - | Option to Purchase Class A Common Stock | |
| Funko Inc (Class A) | Trevor A. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 25,500 | 25,500 | - | - | Option to Purchase Class A Common Stock | |
| Funko Inc (Class A) | Diane M. Irvine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 25,500 | 25,500 | - | - | Option to Purchase Class A Common Stock | |
| Funko Inc (Class A) | Sarah Kirshbaum Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 25,500 | 25,500 | - | - | Option to Purchase Class A Common Stock | |
| Funko Inc (Class A) | Jesse Jacobs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 25,500 | 25,500 | - | - | Option to Purchase Class A Common Stock | |
| Funko Inc (Class A) | Michael Kerns | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 25,500 | 25,500 | - | - | Option to Purchase Class A Common Stock | |
| eXp World Holdings Inc | Glenn Sanford | Director, CEO and Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.94 per share. | 04 Jun 2024 | 25,000 | 41,538,393 (64%) | 0% | 10.9 | 273,593 | Common Stock |
| Sangamo Therapeutics Inc | H. Stewart Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 25,000 | 87,600 (0%) | 0% | 0 | Common Stock | |
| Sangamo Therapeutics Inc | James R. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 25,000 | 74,600 (0%) | 0% | 0 | Common Stock | |
| Sangamo Therapeutics Inc | Margaret A. Horn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 25,000 | 57,650 (0%) | 0% | 0 | Common Stock | |
| Sangamo Therapeutics Inc | Robert F. Carey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 25,000 | 74,600 (0%) | 0% | 0 | Common Stock | |
| Sangamo Therapeutics Inc | Kenneth J. Hillan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 25,000 | 74,600 (0%) | 0% | 0 | Common Stock | |
| Sangamo Therapeutics Inc | Karen L. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 25,000 | 77,100 (0%) | 0% | 0 | Common Stock | |
| Sangamo Therapeutics Inc | John H. Markels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 25,000 | 71,384 (0%) | 0% | 0 | Common Stock | |
| Sangamo Therapeutics Inc | Courtney Beers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 25,000 | 57,650 (0%) | 0% | 0 | Common Stock | |
| Teads Holding Co. | Wenkai Bradshaw | CAO & SVP Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 24,500 | 114,155 | - | 0 | Common Stock | |
| Teads Holding Co. | Jason Kiviat | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 24,000 | 24,000 | - | - | Performance Stock Units | |
| IES Holdings Inc | Jeffrey L. Gendell | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 137.81 per share. | 04 Jun 2024 | 23,811 | 11,322,095 (53%) | 0% | 137.8 | 3,281,394 | Common Stock, par value $0.01 per share |
| AlTi Global Inc (Class A) | Stephen Yarad | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 23,729 | 23,729 | - | - | Restricted Stock Units | |
| Udemy Inc | Natalie Rothman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 23,427 | 66,181 | - | 0 | Common Stock | |
| Udemy Inc | Eren Bali | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 23,427 | 1,669,477 | - | 0 | Common Stock | |
| Udemy Inc | Heather Hiles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 23,427 | 57,507 | - | 0 | Common Stock | |
| Udemy Inc | Lydia Paterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 23,427 | 58,873 | - | 0 | Common Stock | |
| Udemy Inc | Jeffrey Lieberman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 23,427 | 57,507 | - | 0 | Common Stock | |
| Cytokinetics Inc | Robert I. Blum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 48.85 per share. | 04 Jun 2024 | 22,500 | 439,145 (0%) | 0% | 48.9 | 1,099,125 | Common Stock |
| Park-Ohio Holdings Corp | Matthew V. Crawford | Director, CEO, COB, President, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.15 per share. | 04 Jun 2024 | 22,175 | 854,021 (6%) | 0% | 26.1 | 579,876 | Common Stock |
| Steris PLC | Michael J. Tokich | Sr. Vice Pres., CFO | 04 Jun 2024 | 21,720 | 21,720 | - | - | Employee Stock Option (right to buy) | ||
| Udemy Inc | Sohaib Abbasi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 20,988 | 56,744 | - | 0 | Common Stock | |
| CVRx Inc | Joseph P. Slattery | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 20,961 | 20,961 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 20,961 | 20,961 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Mudit K. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 20,961 | 20,961 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Kirk Nielsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 20,961 | 20,961 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Martha Shadan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 20,961 | 20,961 | - | - | Stock Option (right to buy) | |
| Matador Resources Co | Joseph Wm. Foran | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 20,667 | 0 | - | - | Phantom Units | |
| Houlihan Lokey Inc (Class A) | David A. Preiser | Director, CO-PRESIDENT | 04 Jun 2024 | 20,000 | 20,000 (0%) | 0% | 0 | CLASS A COMMON STOCK | ||
| Houlihan Lokey Inc (Class A) | David A. Preiser | Director, CO-PRESIDENT | 04 Jun 2024 | 20,000 | 0 | - | - | CLASS B COMMON STOCK | ||
| Houlihan Lokey Inc (Class A) | David A. Preiser | Director, CO-PRESIDENT | Sale of securities on an exchange or to another person at price $ 133.21 per share. | 04 Jun 2024 | 20,000 | 0 (0%) | 0% | 133.2 | 2,664,200 | CLASS A COMMON STOCK |
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 04 Jun 2024 | 20,000 | 164,433 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 04 Jun 2024 | 20,000 | 604,205 | - | 8.4 | 168,652 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 04 Jun 2024 | 20,000 | 624,205 | - | 1.0 | 19,800 | Common Stock | |
| Church & Dwight | Ravichandra K. Saligram | Director | Sale of securities on an exchange or to another person at price $ 107.67 per share. | 04 Jun 2024 | 20,000 | 13,793 (0%) | 0% | 107.7 | 2,153,400 | Common Stock |
| Teads Holding Co. | Yaffa Krindel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 20,000 | 64,777 | - | 0 | Common Stock | |
| Teads Holding Co. | Nithya B. Das | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 20,000 | 50,000 | - | 0 | Common Stock | |
| Teads Holding Co. | Shlomo Dovrat | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 20,000 | 50,000 | - | 0 | Common Stock | |
| Teads Holding Co. | Arne Wolter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 20,000 | 52,500 | - | 0 | Common Stock | |
| Teads Holding Co. | Kathryn Taneyhill Jhaveri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 20,000 | 52,500 | - | 0 | Common Stock | |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 103.18 per share. | 04 Jun 2024 | 19,674 | 1,677,726 (3%) | 0% | 103.2 | 2,029,892 | Class A Common Stock |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 99.41 per share. | 04 Jun 2024 | 19,549 | 1,750,694 (3%) | 0% | 99.4 | 1,943,366 | Class A Common Stock |
| Arteris Inc | S. Atiq Raza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 19,287 | 48,314 | - | 0 | Common Stock | |
| Arteris Inc | Claudia F. Munce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 19,287 | 80,012 | - | 0 | Common Stock | |
| Arteris Inc | Raman K. Chitkara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 19,287 | 137,028 | - | 0 | Common Stock | |
| Arteris Inc | Isabelle F. Geday | Director | 04 Jun 2024 | 19,287 | 136,763 | - | 0 | Common Stock | ||
| Arteris Inc | Antonio J. Viana | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 19,287 | 51,096 | - | 0 | Common Stock | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.44 per share. | 04 Jun 2024 | 18,830 | 134,770 | - | 33.4 | 629,745 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.44 per share. | 04 Jun 2024 | 18,595 | 135,005 | - | 33.4 | 621,783 | Class A Common Stock |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 103.95 per share. | 04 Jun 2024 | 18,343 | 1,659,383 (3%) | 0% | 104.0 | 1,906,808 | Class A Common Stock |
| Catalyst Pharma Inc | Richard J. Daly | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.98 per share. | 04 Jun 2024 | 17,323 | 234,824 (0%) | 0% | 16.0 | 276,735 | Common stock, par value $0.001 per share |
| IES Holdings Inc | Jeffrey L. Gendell | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 134.87 per share. | 04 Jun 2024 | 17,279 | 11,367,566 (53%) | 0% | 134.9 | 2,330,419 | Common Stock, par value $0.01 per share |
| Graham Corp | Daniel J. Thoren | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 16,628 | 16,628 | - | - | Restricted Stock Units | |
| Paramount Global | Judith A. McHale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 16,195 | 16,195 | - | - | Restricted Share Units | |
| Paramount Global | Charles E. Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 16,195 | 16,195 | - | - | Restricted Share Units | |
| Paramount Global | Linda M. Griego | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 16,195 | 16,195 | - | - | Restricted Share Units | |
| Paramount Global | Shari E. Redstone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 16,195 | 16,195 | - | - | Restricted Share Units | |
| Paramount Global | Barbara M. Byrne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 16,195 | 16,195 | - | - | Restricted Share Units | |
| Paramount Global | Susan Schuman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 16,195 | 16,195 | - | - | Restricted Share Units | |
| Palo Alto | Lee Klarich | EVP, Chief Product Officer | Sale of securities on an exchange or to another person at price $ 290.41 per share. | 04 Jun 2024 | 15,804 | 198,421 (0%) | 0% | 290.4 | 4,589,687 | Common Stock |
| Steris PLC | J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 15,684 | 15,684 | - | - | Employee Stock Option (right to buy) | |
| Sprout Social Inc (Class A) | Ryan Barretto | President | Sale of securities on an exchange or to another person at price $ 32.14 per share. | 04 Jun 2024 | 15,586 | 484,115 (1%) | 0% | 32.1 | 500,872 | Class A Common Stock |
| NET Power Inc (Class A) | Ralph Alexander | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 15,369 | 36,813 | - | 0 | Restricted Stock Units | |
| NET Power Inc (Class A) | Joseph T. Kelliher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 15,369 | 36,813 | - | 0 | Restricted Stock Units | |
| NET Power Inc (Class A) | A. Alejandra Veltmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 15,369 | 36,813 | - | 0 | Restricted Stock Units | |
| NET Power Inc (Class A) | Carol Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 15,369 | 36,813 | - | 0 | Restricted Stock Units | |
| Snowflake Inc (Class A) | Christian Kleinerman | EVP, Product Management | Sale of securities on an exchange or to another person at price $ 137.14 per share. | 04 Jun 2024 | 15,000 | 757,597 | - | 137.1 | 2,057,100 | Class A Common Stock |
| BTCS Inc | Melanie Pump | Director | Sale of securities on an exchange or to another person at price $ 1.56 per share. | 04 Jun 2024 | 14,998 | 37,414 | - | 1.6 | 23,397 | Common Stock |
| Claros Mortgage Trust Inc | Vincent S. Tese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 14,869 | 14,869 | - | - | DEFERRED STOCK UNITS | |
| Claros Mortgage Trust Inc | W. Edward Walter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 14,869 | 14,869 | - | - | DEFERRED STOCK UNITS | |
| Claros Mortgage Trust Inc | Derrick D. Cephas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 14,869 | 14,869 | - | - | DEFERRED STOCK UNITS | |
| Claros Mortgage Trust Inc | Mary Haggerty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 14,869 | 30,705 | - | 0 | COMMON STOCK | |
| Claros Mortgage Trust Inc | Steven L. Richman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 14,869 | 14,869 | - | - | DEFERRED STOCK UNITS | |
| Claros Mortgage Trust Inc | Pamela Liebman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 14,869 | 34,505 | - | 0 | COMMON STOCK | |
| Booz Allen Hamilton Holding Corp (Class A) | Charles O Rossotti | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Jun 2024 | 14,000 | 11,673 (0%) | 0% | 0 | Class A Common Stock | |
| Corcept Therapeutics Inc | G. Charles Robb | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.29 per share. | 04 Jun 2024 | 14,000 | 37,115 (0%) | 0% | 3.3 | 46,060 | Common Stock |
| Corcept Therapeutics Inc | G. Charles Robb | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 14,000 | 36,037 | - | - | Stock option (right to buy) | |
| Roblox Corp (Class A) | Arvind Chakravarthy | Chief People & Systems Officer | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 04 Jun 2024 | 13,970 | 308,996 | - | 35 | 488,950 | Class A Common Stock |
| Q2 Holdings Inc | Jeffrey T. Diehl | Director | 04 Jun 2024 | 13,932 | 707,252 (1%) | 0% | 61.1 | 850,967 | Common Stock | |
| Flex Ltd | Paul R. Lundstrom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 32.53 per share. | 04 Jun 2024 | 13,725 | 494,027 (0%) | 0% | 32.5 | 446,515 | Ordinary Shares |
| Mirion Tech Inc (Class A) | John W. Kuo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 13,500 | 70,069 | - | 0 | Class A Common Stock | |
| Mirion Tech Inc (Class A) | Lawrence D. Kingsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 13,500 | 51,525 | - | 0 | Class A Common Stock | |
| Mirion Tech Inc (Class A) | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 13,500 | 45,441 | - | 0 | Class A Common Stock | |
| Mirion Tech Inc (Class A) | Steven W. Etzel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 13,500 | 70,069 | - | 0 | Class A Common Stock | |
| Mirion Tech Inc (Class A) | Kenneth C. Bockhorst | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 13,500 | 69,209 | - | 0 | Class A Common Stock | |
| Mirion Tech Inc (Class A) | Markopoulos Anne Jody | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 13,500 | 61,137 | - | 0 | Class A Common Stock | |
| Mirion Tech Inc (Class A) | Sheila Rege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 13,500 | 34,517 | - | 0 | Class A Common Stock | |
| Offerpad Soln Inc (Class A) | Kenneth D. Degiorgio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 13,333 | 101,963 | - | 0 | Class A Common Stock | |
| Offerpad Soln Inc (Class A) | Sheryl D. Palmer | Director | 04 Jun 2024 | 13,333 | 38,320 | - | 0 | Class A Common Stock | ||
| Offerpad Soln Inc (Class A) | Ryan O’Hara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 13,333 | 36,653 | - | 0 | Class A Common Stock | |
| Offerpad Soln Inc (Class A) | Katie Curnutte | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 13,333 | 21,288 | - | 0 | Class A Common Stock | |
| Sarcos Tech and Robotics Corp | Dennis M. Weibling | Director | Purchase of securities on an exchange or from another person at price $ 1.63 per share. | 04 Jun 2024 | 12,852 | 162,852 | - | 1.6 | 20,977 | Common Stock |
| Steris PLC | Daniel A. Carestio | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 12,849 | 56,316 (0%) | 0% | 0 | Ordinary Shares | |
| Flex Ltd | Kwang Hooi Tan | Group President | Sale of securities on an exchange or to another person at price $ 32.53 per share. | 04 Jun 2024 | 12,626 | 151,030 (0%) | 0% | 32.5 | 410,773 | Ordinary Shares |
| Robinhood Markets Inc (Class A) | Daniel M Gallagher | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 21.05 per share. | 04 Jun 2024 | 12,500 | 943,815 | - | 21.0 | 263,063 | Class A Common Stock |
| SEACOR Marine Holdings Inc | Andrew R. Morse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 12,390 | 148,340 (0%) | 0% | 0 | Common Stock | |
| Five9 Inc | Michael Burkland | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 46.30 per share. | 04 Jun 2024 | 12,386 | 266,083 (0%) | 0% | 46.3 | 573,472 | Common Stock |
| Palo Alto | Lee Klarich | EVP, Chief Product Officer | Sale of securities on an exchange or to another person at price $ 289.72 per share. | 04 Jun 2024 | 12,317 | 214,225 (0%) | 0% | 289.7 | 3,568,518 | Common Stock |
| Steris PLC | Cary L Majors | SVP and President, Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 12,200 | 12,200 | - | - | Employee Stock Option (right to buy) | |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 102.08 per share. | 04 Jun 2024 | 11,998 | 1,697,400 (3%) | 0% | 102.1 | 1,224,732 | Class A Common Stock |
| Axogen Inc | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 11,904 | 0 | - | - | Restricted Stock Units | |
| Axogen Inc | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 11,904 | 283,498 (0%) | 0% | 0 | Common Stock | |
| Coherent Corp | Joseph J. Corasanti | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 11,440 | 0 | - | - | Option (Right to buy) | |
| Coherent Corp | Joseph J. Corasanti | Director | Sale of securities on an exchange or to another person at price $ 65.80 per share. | 04 Jun 2024 | 11,440 | 89,811 (0%) | 0% | 65.8 | 752,798 | Common Stock |
| Coherent Corp | Joseph J. Corasanti | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.99 per share. | 04 Jun 2024 | 11,440 | 101,251 (0%) | 0% | 14.0 | 160,046 | Common Stock |
| Flex Ltd | D. Offer | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 32.53 per share. | 04 Jun 2024 | 11,354 | 134,338 (0%) | 0% | 32.5 | 369,342 | Ordinary Shares |
| Flex Ltd | Michael Hartung | Group President | Sale of securities on an exchange or to another person at price $ 32.53 per share. | 04 Jun 2024 | 11,353 | 174,206 (0%) | 0% | 32.5 | 369,344 | Ordinary Shares |
| Take-Two Interactive Software | Karl Slatoff | President | Gift of securities by or to the insider at price $ 165.96 per share. | 04 Jun 2024 | 11,237 | 33,712 (0%) | 0% | 166.0 | 1,864,893 | Common Stock |
| HighPeak Energy Inc | Larry C. Oldham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 11,203 | 54,636 | - | 0 | Common Stock, par value $0.0001 per share | |
| Sarcos Tech and Robotics Corp | Benjamin G. Wolff | Director, PRESIDENT & CEO | Purchase of securities on an exchange or from another person at price $ 1.67 per share. | 04 Jun 2024 | 11,101 | 1,299,047 | - | 1.7 | 18,559 | Common Stock |
| Jamf Holding Corp | John Strosahl | Director, CEO | Sale of securities on an exchange or to another person at price $ 15.42 per share. | 04 Jun 2024 | 10,795 | 1,033,170 | - | 15.4 | 166,461 | Common Stock |
| HighPeak Energy Inc | Keith A. Covington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,669 | 51,034 | - | 0 | Common Stock, par value $0.0001 per share | |
| HighPeak Energy Inc | Jay M. Chernosky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,669 | 47,220 | - | 0 | Common Stock, par value $0.0001 per share | |
| HighPeak Energy Inc | Sharon F. Fulgham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,669 | 54,040 | - | 0 | Common Stock, par value $0.0001 per share | |
| HighPeak Energy Inc | Jason A. Edgeworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,669 | 28,006 | - | 0 | Common Stock, par value $0.0001 per share | |
| European Wax Center Inc (Class A) | Darvin D. Lively | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,638 | 62,683 | - | 0 | Class A Common Stock | |
| European Wax Center Inc (Class A) | Laurie Ann Goldman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,638 | 43,183 | - | 0 | Class A Common Stock | |
| European Wax Center Inc (Class A) | Nital Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,638 | 33,606 | - | 0 | Class A Common Stock | |
| Teads Holding Co. | Wenkai Bradshaw | CAO & SVP Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,500 | 10,500 | - | - | Performance Stock Units | |
| Flywire Corp | Diane E. Offereins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,466 | 30,229 | - | 0 | Voting Common Stock | |
| Flywire Corp | Phillip J. Riese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,466 | 217,503 | - | 0 | Voting Common Stock | |
| Flywire Corp | Edwin J. Santos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,466 | 20,914 | - | 0 | Voting Common Stock | |
| Flywire Corp | Alex Finkelstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,466 | 242,283 | - | 0 | Voting Common Stock | |
| Flywire Corp | Gretchen Howard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,466 | 21,881 | - | 0 | Voting Common Stock | |
| Steris PLC | Mary Clare Fraser | SVP & Chief HRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,456 | 10,456 | - | - | Employee Stock Option (right to buy) | |
| Aldeyra Therapeutics Inc | Richard Douglas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,418 | 10,418 | - | - | Stock Option (Right to Buy) | |
| Snap-on | Nicholas T. Pinchuk | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 266.16 per share. | 04 Jun 2024 | 10,375 | 764,507 (1%) | 0% | 266.2 | 2,761,420 | Common Stock |
| Funko Inc (Class A) | Charles D. Denson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,204 | 10,204 | - | - | Restricted Stock Units | |
| Funko Inc (Class A) | Trevor A. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,204 | 10,204 | - | - | Restricted Stock Units | |
| Funko Inc (Class A) | Diane M. Irvine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,204 | 10,204 | - | - | Restricted Stock Units | |
| Funko Inc (Class A) | Sarah Kirshbaum Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,204 | 10,204 | - | - | Restricted Stock Units | |
| Funko Inc (Class A) | Jesse Jacobs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,204 | 10,204 | - | - | Restricted Stock Units | |
| Funko Inc (Class A) | Michael Kerns | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 10,204 | 10,204 | - | - | Restricted Stock Units | |
| Snap-on | Nicholas T. Pinchuk | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 267.02 per share. | 04 Jun 2024 | 10,037 | 754,470 (1%) | 0% | 267.0 | 2,680,107 | Common Stock |
| SS&C Tech Holdings Inc | Michael J. Zamkow | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.38 per share. | 04 Jun 2024 | 10,000 | 51,576 (0%) | 0% | 22.4 | 223,750 | Common Stock |
| SS&C Tech Holdings Inc | Michael J. Zamkow | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 10,000 | 7,500 | - | - | Stock Option (right to buy) | |
| SS&C Tech Holdings Inc | Michael J. Zamkow | Director | Sale of securities on an exchange or to another person at price $ 61.69 per share. | 04 Jun 2024 | 10,000 | 41,576 (0%) | 0% | 61.7 | 616,925 | Common Stock |
| Emergent Biosolutions Inc | Kathryn C. Zoon | Director | Sale of securities on an exchange or to another person at price $ 6.11 per share. | 04 Jun 2024 | 10,000 | 54,482 (0%) | 0% | 6.1 | 61,100 | Common Stock |
| Grid Dynamics Holdings Inc (Class A) | Leonard Livschitz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 9.24 per share. | 04 Jun 2024 | 10,000 | 3,585,901 | - | 9.2 | 92,353 | Common Stock |
| HNI Corp | Donna D. Meade | VP, Member Relations | 04 Jun 2024 | 10,000 | 42,308 (0%) | 0% | 32.0 | 320,300 | Common Stock | |
| HNI Corp | Donna D. Meade | VP, Member Relations | 04 Jun 2024 | 10,000 | 32,308 (0%) | 0% | 46.0 | 459,700 | Common Stock | |
| HNI Corp | Donna D. Meade | VP, Member Relations | 04 Jun 2024 | 10,000 | 0 | - | - | Non-qualifying employee stock options (right to buy) | ||
| Priority Technology Holdings | Timothy M. O’Leary | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.10 per share. | 04 Jun 2024 | 10,000 | 59,752 (0%) | 0% | 4.1 | 41,000 | Common Stock |
| Owens & Minor Inc | Snehashish Sarkar | EVP, Chief Information Officer | 04 Jun 2024 | 9,980 | 59,137 (0%) | 0% | 17.3 | 172,854 | Common Stock | |
| Precision Biosciences Inc | Geno J. Germano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 9,826 | 9,826 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Kevin J. Buehler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 9,826 | 9,826 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Samuel C. Wadsworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 9,826 | 9,826 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Melinda Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 9,826 | 9,826 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Stanley R. Frankel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 9,826 | 9,826 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Shari Lisa Pire | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 9,826 | 9,826 | - | - | Restricted Stock Units | |
| SEACOR Marine Holdings Inc | R. Christopher Regan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 9,736 | 52,025 (0%) | 0% | 0 | Common Stock | |
| TELA Bio Inc | Jeffrey Blizard | Director | 04 Jun 2024 | 9,300 | 9,300 | - | - | Stock Option (Right to Buy) | ||
| Flex Ltd | Rebecca S. Sidelinger | Group President | 04 Jun 2024 | 9,285 | 152,628 (0%) | 0% | 32.5 | 302,067 | Ordinary Shares | |
| Crown Holdings Inc | James H. Miller | Director | 04 Jun 2024 | 9,000 | 12,884 (0%) | 0% | 82.9 | 746,377 | Common | |
| Palo Alto | Lee Klarich | EVP, Chief Product Officer | Sale of securities on an exchange or to another person at price $ 292.53 per share. | 04 Jun 2024 | 8,763 | 183,084 (0%) | 0% | 292.5 | 2,563,405 | Common Stock |
| SEACOR Marine Holdings Inc | Julie Persily | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 8,599 | 68,951 (0%) | 0% | 0 | Common Stock | |
| IES Holdings Inc | Jeffrey L. Gendell | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 135.67 per share. | 04 Jun 2024 | 8,342 | 11,359,224 (53%) | 0% | 135.7 | 1,131,759 | Common Stock, par value $0.01 per share |
| Steris PLC | Julia K. Madsen | Senior VP, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 8,336 | 8,336 | - | - | Employee Stock Option (right to buy) | |
| Matador Resources Co | Van H. Singleton | President-Land, A&D, Planning | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 8,334 | 0 | - | - | Phantom Units | |
| Matador Resources Co | G. Gregg Krug | EVP - Mktg and Midstream | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 8,334 | 0 | - | - | Phantom Units | |
| Exelixis Inc | Jack L. Wyszomierski | Director | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 04 Jun 2024 | 8,287 | 349,499 (0%) | 0% | 22 | 182,314 | Common Stock |
| Corcept Therapeutics Inc | G. Charles Robb | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.87 per share. | 04 Jun 2024 | 8,174 | 28,941 (0%) | 0% | 32.9 | 268,679 | Common Stock |
| Celcuity Inc | Richard J. Nigon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 8,153 | 8,153 | - | - | Stock Option (right to buy) | |
| Celcuity Inc | David F. Dalvey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 8,153 | 8,153 | - | - | Stock Option (right to buy) | |
| Celcuity Inc | Leo T. Furcht | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 8,153 | 8,153 | - | - | Stock Option (right to buy) | |
| Celcuity Inc | Polly A. Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 8,153 | 8,153 | - | - | Stock Option (right to buy) | |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 101.19 per share. | 04 Jun 2024 | 8,102 | 1,709,398 (3%) | 0% | 101.2 | 819,839 | Class A Common Stock |
| Beachbody Co Inc (Class A) | Kevin A. Mayer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 8,064 | 43,186 | - | 0 | CLASS A COMMON STOCK | |
| Beachbody Co Inc (Class A) | Bennet Van De Bunt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 8,064 | 16,936 | - | 0 | CLASS A COMMON STOCK | |
| Beachbody Co Inc (Class A) | Kristin Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 8,064 | 12,719 | - | 0 | CLASS A COMMON STOCK | |
| Beachbody Co Inc (Class A) | Michael J. Heller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 8,064 | 8,064 | - | - | Deferred Restricted Stock Units | |
| Beachbody Co Inc (Class A) | Mary Conlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 8,064 | 16,936 | - | 0 | CLASS A COMMON STOCK | |
| Beachbody Co Inc (Class A) | John S. Salter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 8,064 | 16,936 | - | 0 | CLASS A COMMON STOCK | |
| Beachbody Co Inc (Class A) | Ann Lundy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 8,064 | 8,064 | - | - | Deferred Restricted Stock Units | |
| Expensify Inc (Class A) | Ying Vivian Liu | Director | Sale of securities on an exchange or to another person at price $ 1.45 per share. | 04 Jun 2024 | 8,000 | 29,645 | - | 1.5 | 11,600 | Class A Common Stock |
| Steris PLC | Kenneth E. Kohler | SVP & GM, AST | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 7,900 | 7,900 | - | - | Employee Stock Option (right to buy) | |
| Ranger Energy Services Inc (Class A) | Stuart N. Bodden | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 9.63 per share. | 04 Jun 2024 | 7,785 | 324,088 (3%) | 0% | 9.6 | 74,970 | Class A Common Stock |
| Abercrombie & Fitch Co. (Class A) | Nigel Travis | Director | Sale of securities on an exchange or to another person at price $ 173.66 per share. | 04 Jun 2024 | 7,700 | 19,855 (0%) | 0% | 173.7 | 1,337,182 | Class A Common Stock |
| Five9 Inc | Daniel Burkland | Pres. & Chief Revenue Officer | 04 Jun 2024 | 7,698 | 127,635 (0%) | 0% | 46.3 | 356,417 | Common Stock | |
| Ranger Energy Services Inc (Class A) | Melissa Cougle | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 9.60 per share. | 04 Jun 2024 | 7,500 | 71,842 (0%) | 0% | 9.6 | 71,982 | Class A Common Stock |
| Element Soln Inc | Ian G.H. Ashken | Director | Other type of transaction at price $ 0.00 per share. | 04 Jun 2024 | 7,365 | 0 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Element Soln Inc | Ian G.H. Ashken | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 7,365 | 0 | - | - | Restricted Stock Units | |
| Element Soln Inc | Ian G.H. Ashken | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 7,365 | 7,365 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Element Soln Inc | Ian G.H. Ashken | Director | Other type of transaction at price $ 0.00 per share. | 04 Jun 2024 | 7,365 | 7,365 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Element Soln Inc | Christopher T. Fraser | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 7,365 | 0 | - | - | Restricted Stock Units | |
| Element Soln Inc | Christopher T. Fraser | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 7,365 | 54,728 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Element Soln Inc | John C. Myers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 7,365 | 285,351 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Element Soln Inc | John C. Myers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 7,365 | 0 | - | - | Restricted Stock Units | |
| Element Soln Inc | Michael F. Goss | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 7,365 | 17,906 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Element Soln Inc | Michael F. Goss | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 7,365 | 0 | - | - | Restricted Stock Units | |
| Element Soln Inc | Nichelle Maynard-Elliott | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 7,365 | 0 | - | - | Restricted Stock Units | |
| Element Soln Inc | Nichelle Maynard-Elliott | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 7,365 | 32,154 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Element Soln Inc | Elyse Napoli Filon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 7,365 | 17,906 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Element Soln Inc | Elyse Napoli Filon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 7,365 | 0 | - | - | Restricted Stock Units | |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 98.76 per share. | 04 Jun 2024 | 7,257 | 1,770,243 (3%) | 0% | 98.8 | 716,674 | Class A Common Stock |
| ACI Worldwide Inc | Charles E. Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 7,194 | 93,782 (0%) | 0% | 0 | Common Stock | |
| ACI Worldwide Inc | Samir Michael Zabaneh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 7,194 | 36,239 (0%) | 0% | 0 | Common Stock | |
| ACI Worldwide Inc | Adalio T. Sanchez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 7,194 | 18,188 (0%) | 0% | 0 | Common Stock | |
| ACI Worldwide Inc | Janet O. Estep | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 7,194 | 76,788 (0%) | 0% | 0 | Common Stock | |
| ACI Worldwide Inc | Katrinka McCallum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 7,194 | 9,138 (0%) | 0% | 0 | Common Stock | |
| ACI Worldwide Inc | Mary P. Harman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 7,194 | 36,239 (0%) | 0% | 0 | Common Stock | |
| ACI Worldwide Inc | Juan Benitez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 7,194 | 9,138 (0%) | 0% | 0 | Common Stock | |
| Netgear Inc | Shravan K. Goli | Director | Sale of securities on an exchange or to another person at price $ 13.36 per share. | 04 Jun 2024 | 7,032 | 36,281 (0%) | 0% | 13.4 | 93,948 | Common Stock |
| Wesbanco Inc | Todd F. Clossin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.11 per share. | 04 Jun 2024 | 7,025 | 143,547 (0%) | 0% | 29.1 | 204,498 | Common Stock |
| Exponent Inc | Paul R. Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 7,000 | 28,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Exponent Inc | Paul R. Johnston | Director | Sale of securities on an exchange or to another person at price $ 93.63 per share. | 04 Jun 2024 | 7,000 | 79,236 (0%) | 0% | 93.6 | 655,405 | Common Stock |
| Exponent Inc | Paul R. Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.05 per share. | 04 Jun 2024 | 7,000 | 86,236 (0%) | 0% | 29.1 | 203,350 | Common Stock |
| Micron Tech | Sanjay Mehrotra | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 7,000 | 71,284 | - | - | Non-qualified Stock Options | |
| Micron Tech | Sanjay Mehrotra | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.20 per share. | 04 Jun 2024 | 7,000 | 726,049 (0%) | 0% | 28.2 | 197,400 | Common Stock |
| Forward Air Corp | Christine M. Gorjanc | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,963 | 6,963 (0%) | 0% | 0 | Common Stock | |
| Forward Air Corp | Dale W. Boyles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,963 | 6,963 (0%) | 0% | 0 | Common Stock | |
| Five9 Inc | Panos Kozanian | EVP, Product Engineering | Sale of securities on an exchange or to another person at price $ 46.30 per share. | 04 Jun 2024 | 6,893 | 94,477 (0%) | 0% | 46.3 | 319,146 | Common Stock |
| Palo Alto | Lee Klarich | EVP, Chief Product Officer | Sale of securities on an exchange or to another person at price $ 294.63 per share. | 04 Jun 2024 | 6,888 | 169,444 (0%) | 0% | 294.6 | 2,029,391 | Common Stock |
| GoDaddy | Amanpal S. Bhutani | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 138.09 per share. | 04 Jun 2024 | 6,825 | 377,498 (0%) | 0% | 138.1 | 942,457 | Class A Common Stock |
| Palo Alto | Lee Klarich | EVP, Chief Product Officer | Sale of securities on an exchange or to another person at price $ 293.38 per share. | 04 Jun 2024 | 6,752 | 176,332 (0%) | 0% | 293.4 | 1,980,915 | Common Stock |
| SEACOR Marine Holdings Inc | Alfredo Miguel Bejos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,701 | 124,820 (0%) | 0% | 0 | Common Stock | |
| BTCS Inc | Melanie Pump | Director | Sale of securities on an exchange or to another person at price $ 1.55 per share. | 04 Jun 2024 | 6,641 | 30,773 | - | 1.6 | 10,294 | Common Stock |
| Orion Engineered Carbons S.A. | Sandra Niewiem | Sr. VP Global Specialties | Sale of securities on an exchange or to another person at price $ 24.16 per share. | 04 Jun 2024 | 6,601 | 14,099 (0%) | 0% | 24.2 | 159,480 | Common Shares, no par value |
| Palo Alto | Lee Klarich | EVP, Chief Product Officer | Sale of securities on an exchange or to another person at price $ 291.52 per share. | 04 Jun 2024 | 6,574 | 191,847 (0%) | 0% | 291.5 | 1,916,426 | Common Stock |
| Celcuity Inc | Richard E. Buller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,522 | 6,522 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 04 Jun 2024 | 6,458 | 180,200 (0%) | 0% | 1.7 | 10,853 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 6,458 | 0 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 8.01 per share. | 04 Jun 2024 | 6,458 | 170,200 (0%) | 0% | 8.0 | 51,756 | Common Stock |
| TELA Bio Inc | Jeffrey Blizard | Director | 04 Jun 2024 | 6,375 | 6,375 (0%) | 0% | 0 | Common Stock | ||
| Micron Tech | Sanjay Mehrotra | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 126.02 per share. | 04 Jun 2024 | 6,282 | 719,767 (0%) | 0% | 126.0 | 791,658 | Common Stock |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,229 | 6,229 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,229 | 6,229 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,229 | 6,229 | - | - | Stock Option (Right to Buy) | |
| TELA Bio Inc | Lisa N. Colleran | Director | 04 Jun 2024 | 6,200 | 6,200 | - | - | Stock Option (Right to Buy) | ||
| TELA Bio Inc | Vincent J. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,200 | 6,200 | - | - | Stock Option (Right to Buy) | |
| TELA Bio Inc | Kurt Azarbarzin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,200 | 6,200 | - | - | Stock Option (Right to Buy) | |
| TELA Bio Inc | Federica O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,200 | 6,200 | - | - | Stock Option (Right to Buy) | |
| Hippo Holdings Inc | Hugh R. Frater | Director | Grant, award, or other acquisition of securities at price $ 17.73 per share. | 04 Jun 2024 | 6,170 | 11,276 | - | 17.7 | 109,394 | Common Stock |
| Hippo Holdings Inc | John D. Nichols | Director | Grant, award, or other acquisition of securities at price $ 17.73 per share. | 04 Jun 2024 | 6,170 | 10,959 | - | 17.7 | 109,394 | Common Stock |
| Hippo Holdings Inc | Sandra S. Wijnberg | Director | Grant, award, or other acquisition of securities at price $ 17.73 per share. | 04 Jun 2024 | 6,170 | 11,276 | - | 17.7 | 109,394 | Common Stock |
| Hippo Holdings Inc | Lori Dickerson Fouche | Director | Grant, award, or other acquisition of securities at price $ 17.73 per share. | 04 Jun 2024 | 6,170 | 11,276 | - | 17.7 | 109,394 | Common Stock |
| Hippo Holdings Inc | Eric Feder | Director | Grant, award, or other acquisition of securities at price $ 17.73 per share. | 04 Jun 2024 | 6,170 | 11,276 | - | 17.7 | 109,394 | Common Stock |
| Hippo Holdings Inc | Sam Landman | Director | Grant, award, or other acquisition of securities at price $ 17.73 per share. | 04 Jun 2024 | 6,170 | 13,733 | - | 17.7 | 109,394 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.